Andrew A. Bremer

Early Intratracheal Budesonide to Reduce Bronchopulmonary Dysplasia in Extremely Preterm Infants

Time to Full Enteral Feeds and Late-Onset Sepsis in Extremely Preterm Infants

Neurodevelopmental Outcomes of Extremely Preterm Infants Fed Donor Milk or Preterm Infant Formula

Timing of Red Blood Cell Transfusions and Occurrence of Necrotizing Enterocolitis

Eat, Sleep, Console Approach or Usual Care for Neonatal Opioid Withdrawal

Assessment of Corticosteroid Therapy and Death or Disability According to Pretreatment Risk of Death or Bronchopulmonary Dysplasia in Extremely Preterm Infants

Plasma Amino Acids in Early Pregnancy and Midpregnancy and Their Interplay With Phospholipid Fatty Acids in Association With the Risk of Gestational Diabetes Mellitus: Results From a Longitudinal Prospective Cohort

Heterogeneity of Treatment Effects of Hydrocortisone by Risk of Bronchopulmonary Dysplasia or Death Among Extremely Preterm Infants in the National Institute of Child Health and Human Development Neonatal Research Network Trial

Use of term reference infants in assessing the developmental outcome of extremely preterm infants: lessons learned in a multicenter study

Association of Antenatal Steroid Exposure at 21 to 22 Weeks of Gestation With Neonatal Survival and Survival Without Morbidities

The need to study human milk as a biological system

Obesity and Fat Metabolism in Human Immunodeficiency Virus–Infected Individuals: Immunopathogenic Mechanisms and Clinical Implications

What is metabolic syndrome, and why are children getting it?

Increased Chemerin and Decreased Omentin-1 in Both Adipose Tissue and Plasma in Nascent Metabolic Syndrome

Toward a Unifying Hypothesis of Metabolic Syndrome